InfiCure Bio was selected as 2016 Connect Company in Västerbotten for its dedicated and enthusiastic work to develop a scalable business model in a high-tech field. InfiCure Bio is targeting chronic inflammatory and fibrotic conditions. Based on a panel of in vivo models for these conditions the company offers effect tests of anti-inflammatory and anti-fibrotic drugs. The unique fibrosis model offered by InfiCure Bio has recently attracted national as well as international attention and last year the start-up company signed a first contract for a full-service preclinical pilot study to test two substances for an american client in Boston.
More info on company home page